NLINKN1 Chip+PRIME.StudySYNCRStentrode+$75M.SeriesDPRECNLayer 7+FDA.BrkthruPARAMArgo+$20M.SeriesBBLKRKNeuroport+200.ImplantsEMTIVMN8+$45M.SeriesBKRNLFlux+Non-invasiveNRBLEHalo+Consumer.BCINEURONeuroPace+RNS.SystemCOGNICognixion+ALS.TrialFUND.YTD2026$2.8B.SectorTRIALSActive50+.ClinTrialsIMPLNTSHumans~100.Intracrtnl
activeFounded 2012

MindMaze

HQ: Lausanne, SwitzerlandCEO: Tej TadiHeadcount: ~300mindmaze.com
Funding Summary
Total Funding
$125M+
Latest Valuation
$1B+ (2016)
About

MindMaze is a Swiss neurotechnology company developing VR-based neurorehabilitation platforms and BCI-enabled therapeutic systems. The company achieved unicorn status in 2016 after a $100M investment from the Hinduja Group. MindMaze's core platform combines real-time motion capture, virtual reality, and neural feedback to accelerate motor recovery following stroke and traumatic brain injury. The company has partnerships with major hospital systems in Europe and the United States.

Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →